WEBINAR: Turn your Sequencing Lab into a COVID-19 Research and Surveillance Powerhouse
The tracing and tracking of SARS-CoV-2 is an uphill battle that the entire global health community now faces. The SOPHiA GENETICS community is not alone in this fight. With our help, some of the most vital research could be conducted with technology many labs already have in place, by utilizing the power of NGS and Data-Driven Medicine.
Through this May 5th webinar, you can see how to transform your Illumina and MGI sequencers into SARS-CoV-2 research and surveillance powerhouses with guidance from our Senior NGS Scientist, Slawomir Kubik, and Paragon Genomic’s Application Scientists.
The presentation will offer more details about Paragon Genomic’s CleanPlex SARS-CoV-2 Application, including real data on technical and clinical performance.
Additionally, they’ll explain how Paragon’s experience with highly sensitive amplicon sequencing technology is powered by SOPHiA’s tried and true methodology of data enrichment and clinical-grade analytical performance. Through this tag team effort, we can sequence the virus with 99% genome coverage and provide the highest confidence in sequencing output.
High fidelity sequences are paramount to the longitudinal tracking and surveillance of the virus and ensuring this data quality is essential for the management of patients on the front lines.
WHEN: May 5, 2020 Noon EST, 9:00 AM PT
REGISTER:https://us02web.zoom.us/webinar/register/7015878377234/WN_a5dT0E2tQ4OEpxADXbRVqw
For more information, please contact:
Katie King
kking@sophiagenetics.com
720.768.3234